These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 14961569

  • 1. Loss of PKR activity in chronic lymphocytic leukemia.
    Hii SI, Hardy L, Crough T, Payne EJ, Grimmett K, Gill D, McMillan NA.
    Int J Cancer; 2004 Apr 10; 109(3):329-35. PubMed ID: 14961569
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of double-stranded RNA- and tumor necrosis factor alpha-mediated apoptosis by tetratricopeptide repeat protein and cochaperone P58(IPK).
    Tang NM, Korth MJ, Gale M, Wambach M, Der SD, Bandyopadhyay SK, Williams BR, Katze MG.
    Mol Cell Biol; 1999 Jul 10; 19(7):4757-65. PubMed ID: 10373525
    [Abstract] [Full Text] [Related]

  • 3. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
    Eclache V, Caulet-Maugendre S, Poirel HA, Djemai M, Robert J, Lejeune F, Raphaël M.
    Cancer Genet Cytogenet; 2004 Jul 01; 152(1):72-6. PubMed ID: 15193446
    [Abstract] [Full Text] [Related]

  • 4. CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia.
    Thornton PD, Fernandez C, Giustolisi GM, Morilla R, Atkinson S, A'Hern RP, Matutes E, Catovsky D.
    Hematol J; 2004 Jul 01; 5(2):145-51. PubMed ID: 15048065
    [Abstract] [Full Text] [Related]

  • 5. Role of double-stranded RNA-activated protein kinase in human hematological malignancies.
    Basu S, Panayiotidis P, Hart SM, He LZ, Man A, Hoffbrand AV, Ganeshaguru K.
    Cancer Res; 1997 Mar 01; 57(5):943-7. PubMed ID: 9041199
    [Abstract] [Full Text] [Related]

  • 6. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
    Li S, Min JY, Krug RM, Sen GC.
    Virology; 2006 May 25; 349(1):13-21. PubMed ID: 16466763
    [Abstract] [Full Text] [Related]

  • 7. Molecular basis for PKR activation by PACT or dsRNA.
    Li S, Peters GA, Ding K, Zhang X, Qin J, Sen GC.
    Proc Natl Acad Sci U S A; 2006 Jun 27; 103(26):10005-10. PubMed ID: 16785445
    [Abstract] [Full Text] [Related]

  • 8. The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR).
    Huang X, Hutchins B, Patel RC.
    Biochem J; 2002 Aug 15; 366(Pt 1):175-86. PubMed ID: 11985496
    [Abstract] [Full Text] [Related]

  • 9. Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs.
    McKenna SA, Kim I, Liu CW, Puglisi JD.
    J Mol Biol; 2006 May 19; 358(5):1270-85. PubMed ID: 16580685
    [Abstract] [Full Text] [Related]

  • 10. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L, Viaggi S, Zunino A, Zupo S, Rossi E, Spriano M, Abbondandolo A, Ferrarini M.
    Haematologica; 2003 Jul 19; 88(7):769-77. PubMed ID: 12857555
    [Abstract] [Full Text] [Related]

  • 11. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S, Vitelli G, Levato D, Giannarelli D, Vacca A, Cuneo A, Ribatti D, Digiesi G.
    Eur J Haematol; 2004 Jul 19; 73(1):36-42. PubMed ID: 15182336
    [Abstract] [Full Text] [Related]

  • 12. The 58-kDa cellular inhibitor of the double stranded RNA-dependent protein kinase requires the tetratricopeptide repeat 6 and DnaJ motifs to stimulate protein synthesis in vivo.
    Tang NM, Ho CY, Katze MG.
    J Biol Chem; 1996 Nov 08; 271(45):28660-6. PubMed ID: 8910500
    [Abstract] [Full Text] [Related]

  • 13. TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress.
    Daher A, Laraki G, Singh M, Melendez-Peña CE, Bannwarth S, Peters AH, Meurs EF, Braun RE, Patel RC, Gatignol A.
    Mol Cell Biol; 2009 Jan 08; 29(1):254-65. PubMed ID: 18936160
    [Abstract] [Full Text] [Related]

  • 14. The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity.
    Melville MW, Tan SL, Wambach M, Song J, Morimoto RI, Katze MG.
    J Biol Chem; 1999 Feb 05; 274(6):3797-803. PubMed ID: 9920933
    [Abstract] [Full Text] [Related]

  • 15. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

  • 16. Interaction between PKR and PACT mediated by LPS-inducible NF-κB in human gingival cells.
    Yoshida K, Okamura H, Hoshino Y, Shono M, Yoshioka M, Hinode D, Yoshida H.
    J Cell Biochem; 2012 Jan 15; 113(1):165-73. PubMed ID: 21882225
    [Abstract] [Full Text] [Related]

  • 17. trans-Autophosphorylation by the isolated kinase domain is not sufficient for dimerization or activation of the dsRNA-activated protein kinase PKR.
    Wu S, Kaufman RJ.
    Biochemistry; 2004 Aug 31; 43(34):11027-34. PubMed ID: 15323561
    [Abstract] [Full Text] [Related]

  • 18. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM, Bone ND, Stenson MJ, Novak A, Hedin KE, Kay NE, Ansell SM.
    Mayo Clin Proc; 2004 Mar 31; 79(3):318-25. PubMed ID: 15008605
    [Abstract] [Full Text] [Related]

  • 19. Double-stranded RNA-independent dimerization of interferon-induced protein kinase PKR and inhibition of dimerization by the cellular P58IPK inhibitor.
    Tan SL, Gale MJ, Katze MG.
    Mol Cell Biol; 1998 May 31; 18(5):2431-43. PubMed ID: 9566864
    [Abstract] [Full Text] [Related]

  • 20. A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia.
    Murad JM, Tone LG, de Souza LR, De Lucca FL.
    Blood Cells Mol Dis; 2005 May 31; 34(1):1-5. PubMed ID: 15607693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.